Analyst forecasts for MorphoSys balance sheet: Losses and decline in sales expected

Analyst forecasts for MorphoSys balance sheet: Losses and decline in sales expected

According to a report by www.finanzen.net, MorphoSys' financial results for the quarter ended September 30, 2023 will be announced on November 15, 2023. Analysts' average estimates suggest that MorphoSys will report a loss of EUR -2.131 per share, compared to a loss of EUR -3.600 per share in the year-ago quarter. Sales are expected to be EUR 56.7 million, which corresponds to a decrease of 40.78 percent compared to the same quarter of the previous year, in which EUR 95.8 million were generated.

For the entire fiscal year, analysts expect an average loss of EUR -6.840 per share compared to EUR -4.420 in the previous year. Sales are expected to be EUR 233.6 million, compared to EUR 278.3 million last year.

These forecasts indicate that MorphoSys is facing a difficult financial situation. A decline in sales and a higher loss per share compared to the previous year could have a negative impact on the company's share price and investor confidence. Furthermore, this could also affect the company's competitiveness in the industry.

It remains to be seen what the actual business results will be and how the company will respond to these challenges. The market is expected to react strongly to MorphoSys' official figures and strategy. It will be exciting to follow developments in the coming quarters.